Montefiore Medical Center

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

Retrieved on: 
Monday, March 25, 2024
Diagnosis, Neurology, Week, Narcolepsy, Somnolence, Memory, Cataplexy, Central nervous system, Patient, CNS, Montefiore Medical Center, EDS, Concentrate, SYMPHONY, Epworth Sleepiness Scale, Quality of life, Therapy, Cognition, Concurrency, ESS, Reboxetine, Pharmaceutical industry

AXS-12 also reduced excessive daytime sleepiness (EDS) severity, improved cognitive function, and reduced overall narcolepsy severity as compared to placebo.

Key Points: 
  • AXS-12 also reduced excessive daytime sleepiness (EDS) severity, improved cognitive function, and reduced overall narcolepsy severity as compared to placebo.
  • SYMPHONY was a Phase 3 multicenter, randomized, double-blind, placebo-controlled trial in which 90 patients with a diagnosis of narcolepsy with cataplexy were randomized to treatment with AXS-12 or placebo for 5 weeks.
  • “The SYMPHONY Phase 3 trial results confirm the promise and potential of AXS-12 for the treatment of narcolepsy,” said Dr. Herriot Tabuteau, CEO of Axsome Therapeutics.
  • Axsome will host a conference call and webcast today at 8:00 AM Eastern to discuss the topline SYMPHONY study results in narcolepsy.

Acclaimed Clinical Geneticist Dr. Bruce Korf Honored with 2024 David L. Rimoin Lifetime Achievement Award in Medical Genetics from the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Wednesday, March 13, 2024
Department of Defence, Friends, Patient, Medical genetics, Travel, Child, Neurofibromatosis, Practice, UAB, Gene expression, Dean (education), Education, Rockefeller University, Seed, NF, NIH, American College, Pediatrics, Person, Karyotype, MD–PhD, Boston Children's Hospital, Principle, Birmingham School of Law, Neurology, FACOG, Genetics, Cornell University, American Journal, Research, Hospital, University, Human genetics, Student, Publication, DRS, ACMG, Book, Genetic distance, DSM-IV codes, Diagnosis, FACMG, Empathy, Montefiore Medical Center, Distinguishing, Mouse, Hope, Doctor of Philosophy, Life, Genetic, Bangladesh Technical Education Board, Physician, Nursing

BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.

Key Points: 
  • BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
  • Dr. Korf is an authentic, kind and ethical human being whose life and career in medical genetics are unparalleled."
  • "Dr. Korf's extraordinary accomplishments in clinical genetics, neurofibromatosis, and genomics, as well as his dedication to education make him a well deserving winner of the David Rimoin Lifetime Achievement Award.
  • Before he died, David appreciated the opportunity to work with Bruce first-hand in the editing of Principles and Practice of Medical Genetics as well as on numerous committees for the ACMG.

Most Enterprises Will Begin to Address Customer Experience Visibility by 2027, ISG Expert Says

Retrieved on: 
Tuesday, February 20, 2024
Software, Mobile, Wireless, Networks, Professional Services, Data Management, Technology, Artificial Intelligence, Other Communications, Digital Marketing, Security, Communications, Other Technology, Consulting, Managed services, Talent, Montefiore Medical Center, Software as a service, NLU, Organization, Automation, Head, Loyalty, Activision Blizzard, PBS, Comcast, CIO, ISG, L&D, SoulCycle, EMA, Product management, Digital, Telecom, CX, Organization development, Research, Innovation, Marketing, Learning Technology Partners, AI, Intelligence, Procurement, Customer success, Triage, Technology Business Management Council, Engagement, Mastercard, Management

Two-thirds of organizations will begin to streamline analytics, performance and customer data integration efforts by 2027 for better visibility into customer experience and to boost customer loyalty and value, says an expert with leading global technology research and advisory firm Information Services Group ( ISG ) (Nasdaq: III ) and chair of an upcoming ISG event.

Key Points: 
  • Two-thirds of organizations will begin to streamline analytics, performance and customer data integration efforts by 2027 for better visibility into customer experience and to boost customer loyalty and value, says an expert with leading global technology research and advisory firm Information Services Group ( ISG ) (Nasdaq: III ) and chair of an upcoming ISG event.
  • “Customer engagement has often been viewed as a costly necessity that needs to be contained, when, in reality, customer experiences have a direct impact on revenue,” said Keith Dawson, ISG research director and chair of the upcoming ISG Xperience Summit.
  • “AI has already established itself as a powerful presence in the customer experience.
  • By 2025, our research finds seven in 10 customer service interactions will be some combination of automated conversational self-service and live agents.

Rittenhouse Psychiatric Associates Hires Samantha Wyckoff, MD as Director of Addiction Services - Solidifying Focus on a Healthier Philadelphia

Retrieved on: 
Thursday, March 7, 2024
Rittenhouse Square, MAT, MD, Medical director, Friends, Neurology, Addiction psychiatry, Montefiore Medical Center, Anxiety, Diagnosis, Psychiatry, Opioid epidemic, Weill Cornell Medical Center, Nursing

PHILADELPHIA, March 7, 2024 /PRNewswire/ -- In a major move to support Philadelphians toward a healthier future, Rittenhouse Psychiatric Associates— one of the city's largest outpatient mental health practices— has announced the hire of Samantha Wyckoff, MD as their Director of Addiction Services.

Key Points: 
  • PHILADELPHIA, March 7, 2024 /PRNewswire/ -- In a major move to support Philadelphians toward a healthier future, Rittenhouse Psychiatric Associates— one of the city's largest outpatient mental health practices— has announced the hire of Samantha Wyckoff, MD as their Director of Addiction Services.
  • "I am joining Rittenhouse Psychiatric Associates at a critical time for our communities in Philadelphia," said Wyckoff.
  • Dr. Chris Pagnani, MD, Rittenhouse Psychiatric Associates' Founder and Medical Director, added, "Major efforts are being made by Mayor Parker's administration to tackle the opioid epidemic in Philadelphia.
  • Dr. Wyckoff offers substance use disorder services at Rittenhouse Psychiatric Associate's Rittenhouse Square office in Philadelphia and via telepsychiatry to all of Pennsylvania.

World Renowned AC Joint Surgery Specialist Dr. Steven Struhl Recognized as a 2024 Top Patient Rated Doctor from Find Local Doctors

Retrieved on: 
Wednesday, March 6, 2024
Private practice, Arthroscopy, Multimedia, Brooklyn Nets, Physician, Dentist, MIT, Pennsylvania State University, U.S. Open, Montefiore Medical Center, Elective surgery, University, ACL, Doctor, Patient, VIP, Trust, Sports medicine, Research, Shoulder, AC, American Academy, Nursing

NEW YORK CITY, March 6, 2024 /PRNewswire-PRWeb/ -- Dr. Steven Struhl, a leading orthopedic shoulder and knee surgeon who is widely known for his expertise in AC joint repair, has been recognized as a 2024 Top Patient Rated Doctor by Find Local Doctors. Find Local Doctors helps consumers find the most qualified and reputable physicians and dentists in their area. Dr. Struhl has been given this prestigious award based on his excellent ratings and reviews. Whether patients are suffering from knee arthritis or an ACL tear, Dr. Struhl treats each patient like a VIP, providing the best orthopedic care available. With over 100 5-star reviews and a stellar Google average rating, Dr. Struhl's commitment to providing extraordinary service and outstanding results are evident in the feedback from his patients. At his Shoulders & Knees orthopedic clinics in NYC and Westchester, Dr. Struhl offers innovative treatments and advanced care for joint injuries and health conditions. His patented technique for addressing AC joint separation has gained international recognition for its effectiveness. He is dedicated to delivering long-lasting relief for his patients and strives to use the most advanced technology available to ensure the best possible outcomes.

Key Points: 
  • NEW YORK CITY, March 6, 2024 /PRNewswire-PRWeb/ -- Dr. Steven Struhl, a leading orthopedic shoulder and knee surgeon who is widely known for his expertise in AC joint repair , has been recognized as a 2024 Top Patient Rated Doctor by Find Local Doctors.
  • Find Local Doctors helps consumers find the most qualified and reputable physicians and dentists in their area.
  • "I am honored to receive this award and grateful for the trust and support of my patients," says Dr. Steven Struhl.
  • Dr. Steven Struhl is board-certified in both orthopedic surgery and sports medicine/arthroscopic surgery and has been in private practice for over 22 years.

Addressing New York's Youth Mental Health Crisis, Montefiore Announces Plans for New Pediatric Inpatient Psychiatry Unit

Retrieved on: 
Wednesday, March 6, 2024
New York State Assembly, Anxiety, Mental health, New Yorker, Adolescence, Suicidal ideation, Education, HRSA, Montefiore Medical Center, Hospital, Bed, Assembly, Mental, JAMA, Psychosis, Behavioural sciences, Depression, Patient, Pediatrics, Child, Psychiatry, Trauma, Environment, Travel, Intensive outpatient program, Nursing

BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx. The Montefiore Einstein Center for Children's Mental Health of the Children's Hospital at Montefiore Einstein will be funded in part by a nearly $6 million appropriation to Montefiore spearheaded by New York State Assembly Speaker Carl Heastie and Assembly Member Michael Benedetto. The 21-bed child and adolescent unit will be located within the New York City Children's Center (NYCCC) campus adjacent to the Albert Einstein College of Medicine and will serve as a model for urban pediatric inpatient psychiatric services. The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region. The proposed center will be designed to provide best-in-class intensive treatment for youth with serious behavioral health conditions including severe depression, anxiety, trauma, suicidal thoughts, psychosis and other acute psychiatric conditions.

Key Points: 
  • BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx.
  • The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region.
  • As a leading health system in New York renowned for delivering exceptional care, I am confident that Montefiore will exceed in tackling mental health disparities with the new pediatric psychiatry unit," said New York State Assembly Speaker Carl Heastie.
  • The Montefiore pediatric psychiatry unit will provide 24/7 best-in-class care and access to comprehensive evaluation and care administered by mental health professionals expert in pediatric psychiatry.

Montefiore's Albert Einstein College of Medicine Announces Free Tuition in Perpetuity for All Medical School Students

Retrieved on: 
Monday, February 26, 2024
Barnard College, College, Physician, Albert Einstein, Montefiore Medical Center, Treatment, Learning disability, Teachers College, Columbia University, Drug, Child, The College of Medicine, Health, Evaluation, Trustee, Medicine, Columbia University, Science, Marilyn, Research, CERC, Student, Nursing

BRONX, N.Y., Feb. 26, 2024 /PRNewswire/ -- Dr. Philip Ozuah, President and CEO of Montefiore Einstein, the umbrella organization for Albert Einstein College of Medicine and Montefiore Health System, today announced that Albert Einstein College of Medicine has received a transformational gift from Ruth L. Gottesman, Ed.D., Chair of the Einstein Board of Trustees and Montefiore Health System board member. This historic gift – the largest made to any medical school in the country – will ensure that no student at Einstein will have to pay tuition again.

Key Points: 
  • This historic gift – the largest made to any medical school in the country – will ensure that no student at Einstein will have to pay tuition again.
  • With this donation, all current fourth-year students will be reimbursed their spring 2024 semester tuition and, effective beginning in August of this year, all students moving forward will receive free tuition at Albert Einstein College of Medicine.
  • Albert Einstein College of Medicine was founded in 1955 with a mission to welcome all students, without restrictions.
  • "Each year, well over 100 students enter Albert Einstein College of Medicine in their quest for degrees in medicine and science.

PHYSICIAN-SCIENTISTS UNDERREPRESENTED IN MEDICINE TO CONDUCT HEALTH EQUITY RESEARCH AT MONTEFIORE AND EINSTEIN

Retrieved on: 
Tuesday, February 6, 2024
Mortality, Hospital, Research, Obesity, Emotional intelligence, Montefiore Medical Center, HIV/AIDS, Pediatrics, Albert Einstein, Blood, Infant, Lung, Diversity, Epidemiology, National Institutes of Health, Sleep, Inclusion, Diabetes, Bangladesh Technical Education Board, Medicine, Health, Asthma, Montefiore, T32, Nursing

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Montefiore Health System and Albert Einstein College of Medicine have been awarded a $1.5 million National Institutes of Health grant to provide advanced research training to post-graduate trainees from groups that are underrepresented in medicine and have research interests in heart, lung, blood, and sleep disorders. Over five years, nine researchers will receive intense research training and robust mentorship from almost 30 established, senior investigators across Montefiore and Einstein.

Key Points: 
  • Over five years, nine researchers will receive intense research training and robust mentorship from almost 30 established, senior investigators across Montefiore and Einstein.
  • , principal investigator, vice chair for clinical and community-based research at the Children's Hospital at Montefiore and professor of pediatrics at Albert Einstein College of Medicine .
  • The research projects conducted by the nine investigators will aim to understand and reduce these inequities.
  • The T32 Training Program is titled "Purposeful Outreach for Diversity and Inclusion of Underrepresented in Medicine (PODIUM) Physician-Scientists" (1T32HL172255-01) and is intended to support training of postdoctoral trainees at Montefiore and Einstein, institutions uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations.

CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma

Retrieved on: 
Thursday, February 1, 2024
Partnership, Glioblastoma, Inflammation, Research, OTCQB, Montefiore Medical Center, HIV, Leronlimab, Patient, Splenic infarction, Stroke, FDA, Biotechnology, CCR5, Pharmaceutical industry

The Company believes this submission will lead to the removal of the clinical hold currently in effect.

Key Points: 
  • The Company believes this submission will lead to the removal of the clinical hold currently in effect.
  • CytoDyn’s CEO, Dr. Jacob Lalezari stated, “Our HIV protocol has been revised and resubmitted following FDA input, and will study leronlimab in HIV patients who have increased inflammation and immune activation, which causes heart attacks, strokes, and other vascular events.
  • Glioblastoma is a common and often untreatable form of primary brain cancer.
  • CytoDyn is fortunate to be able to evaluate the potential effects of leronlimab in a pre-clinical model of this all too often deadly cancer.”

Dr. Frank Lalezar Continues Partnership With Haute Beauty Network

Retrieved on: 
Tuesday, January 30, 2024
Partnership, Plastic surgery, Science, Montefiore Medical Center, Expert, Patient, Dream, Love, Face, Stony Brook University Hospital, Aesthetics, Dentistry

NEW YORK, Jan. 30, 2024 /PRNewswire-PRWeb/ -- Dr. Frank Lalezar is a board-Certified, Ivy League-educated, plastic surgeon practicing in Manhattan, New York. Dr. Lalezar specializes in Aesthetic Plastic Surgery of the Face, Breasts, and Body.

Key Points: 
  • Breast Expert from New York, Dr. Frank Lalezar, continues his partnership with Haute Beauty Network, now in his second year.
  • Dr. Lalezar specializes in Aesthetic Plastic Surgery of the Face, Breasts, and Body.
  • Dr. Lalezar is a prolific author and speaker, consistently being invited to lecture about innovations in Plastic and Aesthetic Surgery.
  • Over the course of his career, Dr. Lalezar has authored numerous peer-reviewed publications in leading Plastic Surgery journals, always striving to improve and advance the field of Plastic and Aesthetic surgery.